Webinars & Video Resources

WEBINARS

Save Your Skin Foundation webinars are a great way to stay updated by listening to patients, survivors, doctors, and pharmaceutical company executives discuss the melanoma landscape. Each webinar features a variety of experts and discusses a different topic. Below is information on upcoming webinars, and links to audio recordings of past webinars.

A Global Perspective on the Changing Face of Cancer

Thursday, March 13, 2017 at 8am PST | 11am EST

With Dr. Jason Luke from Chicago, USA, and Dr. Marcus Butler from Toronto, Canada 

 

This webinar explores the evolution of cancer treatments and the cancer patient, how new innovations in cancer care and personalized treatment have changed quality of life and side effects for patients, and will provide an international lens on how scientists and researchers are harnessing these new innovations to find a cure.

Current Melanoma Treatments in Canada: What Patients Need to Know

Thursday, March 9, 2017 at 2pm EST | 12pm MDT | 11am PST

With Dr. Wilson Miller, Professor in the Departments of Oncology and Medicine, McGill University and Director of the Clinical Research Unit at the Jewish General Hospital

 

This webinar is intended to educate patients on the current landscape of melanoma treatments in Canada, which treatment options are on the horizon, and the clinical trials for melanoma currently underway in Quebec.

Clinical Trials: What Patients Need to Know

Thursday, February 9, 2017 at 2pm EST | 12pm MDT | 11am PST

With Dr. Natasha Kekre, Associate Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute

This webinar is to educate patients about clinical trials: where to find information about them, what their purpose is, how they work, who is eligible, and why one should participate.  This webinar discusses the important position clinical trials hold in the treatment of cancers and other illnesses and provide the patient with information regarding the process of finding and participating in clinical trials, their eligibility for clinical trials, and any other questions they might have.

Patients now also have access to a digital cancer registry where they can get information on what trials are being conducted and where, click here to learn more.

Understanding your Pathology Report

Thursday, October 13, 2016 at 12pm EDT | 10am MDT | 9am PDT
With Dr. Alan Spatz, MD  Director, Pathology Department, Jewish General Hospital & Professor, Pathology and Oncology, McGill University
To diagnose diseases such as cancer, a sample of tissue called a biopsy is taken from a patient and examined by a pathologist to determine if cancer is present. A pathologist will then examine specimens removed during surgery (resections) for conditions such as cancer, to determine whether the tumour is benign or cancerous, and if cancerous, the exact cell type, grade and stage of the tumour. The pathologist, who is a member of your medical team, writes the pathology report that your treating doctor uses to provide the best care for you as a patient. In this webinar, Dr. Alan Spatz provides insight on understanding your pathology report so that you can play an active role in your treatment.

Post-ASCO Webinar with Dr. Omid Hamid

Friday, August 26, 2016 at 4pm PDT | 5pm MDT | 7pm EDT

With Dr. Omid Hamid, Director of the Melanoma Center at The Angeles Clinic and Research Institute

This webinar reviews late breaking news, key takeaways, clinical data and other updates presented at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting that took place in June 2016 in Chicago, Illinois.  Dr. Hamid will share his key insights into what the landscape of melanoma treatment looks like for the near future.  As the  Director of the Melanoma Center at The Angeles Clinic and Research Institute, Dr. Omid Hamid works to ensure that patients receive access to the most up-to-date therapeutics, based on molecular pathways of melanoma progression.  Most recently, in his role with the Phase 1 Developmental Therapeutics Program, Dr. Hamid has been instrumental in bringing new therapies from the investigational lab to the clinic for patient benefit.  These therapies involve immunological therapies such as PD-1 inhibitors, therapies against tumor angiogenesis, and targeted agents that block internal processes in tumor cell’s function.

Please see below for more past webinars (some with audio recording).  To view archived recordings, click on links where indicated and simply register with your name and email address.  Each registration is free and unlimited:

 

The Pharmacoeconomics of Cancer Drugs
Friday, February 26, 2016 at 12pm EST | 10am MST | 9am PST

With Frédéric Lavoie, Professor of Economics at Université de Montreal and Head, Oncology Policy and Reimbursement at Novartis Canada

With new breakthroughs in cancer care and the subsequent rise in costs for these treatments, health economics is playing an increasingly important role in health care. What is pharmacoeconomics and what role does it play in the Canadian Health Care System and in the reimbursement decision-making process? This webinar provides a greater understanding of what pharmacoeconomics is from a Canadian perspective and what this means for the cancer patient.

Missed the webinar? Listen to a recording of the presentation here.

Melanoma: A Year at a Glance
Friday, January 29, 2016 at  7am EST | 4am PST | 2pm CET

This webinar facilitates an open discussion with oncologists on what was new in melanoma treatment options in 2015 and what we hope to see in 2016. The panel will bring together Dr. Omid Hamid, Director of the Melanoma Center at The Angeles Clinic and Research Institute; Dr. Reinhard Dummer, Vice-Chairman of the Department of Dermatology and Head of the Skin Cancer Unit at the University Hospital of Zürich; and Dr. Wilson Miller, Professor of Departments of Oncology and Medicine, McGill University and Director of the Clinical Research Unit at the Jewish General Hospital in Montreal, Quebec.

Missed the webinar? Listen to a recording of the presentation here.

Post-SMR Webinar
Thursday, January 14, 2016 at 12pm EST | 10am MST | 9am PST

The first medical webinar in our new “Spotlight on Skin Cancer” series, will be a Post-Society for Melanoma Research Conference with Dr. Winson Y. Cheung, Medical Oncologist at the British Columbia Cancer Agency. Dr. Cheung will share updates and key findings presented at the 2015 Society for Melanoma Conference in San Francisco, California.  As well as the information provided, participants will have the opportunity to discuss key takeaways, late breaking news and clinical data with colleagues from across Canada.

Missed the webinar? Listen to a recording of the presentation here.

The Drug Evaluation Process: Patient Input Submissions and Responsible Advocacy for New Treatment

Thursday, December 17, 2015 at 2am EST | 12pm MST | 11am PST
With Bill Dempster from 3Sixty Public Affairs

This webinar discusses the process used to evaluate drugs, concluding with recommendations about whether they should be covered by provincial formularies. In particular, this webinar will look at how patients can engage in the process.  The presentation addresses the following topics:

When and how can patients engage with the drug evaluation process?
What are the best practices to promote the patient’s voice?
Looking ahead: how can we improve patients’ opportunities to engage?

Missed the webinar? Listen to a recording of the presentation here.

Canadian Cancer Therapy Approval, Evaluation and Funding Process: What is the Role of the Patient?

Tuesday, December 8, 2015 at 2am EST | 12pm MST | 11am PST
With Gerry Jeffcott and Bill Dempster from 3Sixty Public Affairs

This webinar provides insight into how cancer drugs are reviewed by Health Canada, through the multi-step decision-making process that determines whether they are covered by public and private formularies.  The presentation will address the following topics:
What are the different steps to bring a new cancer drug to patients?
Where can patients make a difference?
How is the patient role changing?

Missed the webinar? Listen to a recording of the presentation here.

Surviving Melanoma: A Discussion on Survivorship

Thursday, April 30th 2015 at 9:45 AM PST

With Kathy Barnard, Nigel Deacon, Terry Jaillet, Natalie Richardson

Life after cancer can be anything but ordinary. Join Kathy Barnard, President and Founder of the Save Your Skin Foundation, along with a panel of survivors from across Canada as they discuss their personal stories, struggles, triumphs, what survivorship means and how they got there. Melanoma month kicks off with this webinar to inspired hope that surviving cancer is possible, whether you have melanoma or another form of cancer.

 Missed the webinar? Listen to a recording of the presentation here.

Are you Ready for your Meeting with your Oncologist?

Wednesday, March 18th, 2015 at 10 AM PST

With Laura Wilson, Symptoms Management and Drug Access Nurse- Lions Gate Hospital, North Vancouver

In this webinar, Laura Wilson discusses the important factors to consider before meeting your Oncologist so that you can ask the right questions to make informed decisions and be an active participant in your cancer care.

Questions asked after the webinar include: At which point should an Oncologist be part of my team if I am diagnosed with stage 1 or 2 (or maybe 3) melanoma? Should I be seeing an Oncologist even if I had my melanoma surgically removed by my Dermatologist?

Laura Wilson’s answer: It never hurts to be referred, it is probably less important for a stage 1 but is definitely important for a stage 2 or 3.

Missed the webinar? Listen to a recording of the presentation here.

View the slides from this presentation on slideshare here.

Le Cancer de la Peau au Quebec (French)

Friday, Februrary 27, 2015 at 10am PST

With Dr. Claveau, Dermato-Oncologist- Hopital Dieu de Quebéc, Quebéc

In this webinar, Dr. Claveau prevents an overview of skin cancer in Quebéc and treatment options, with a focus on melanoma.

The Melanoma Landscape in Canada Today

Friday, February 13, 2015 at 10am PST

With Dr. Michael Smylie, Medical Oncologist- Cross Cancer Institute, Edmonton, Alberta

Over the past few years, the landscape of melanoma has changed dramatically with the arrival of new therapies. In this webinar, Dr. Smylie walks us through those changes and helps us to understand what treatment options are available today.

Patients benefit from Education Initiatives

Making awareness and education available is crucial. Since 2006, the Foundation has worked to raise awareness of melanoma and non-melanoma skin cancers focusing on education, prevention and the need for improved patient care.

Show Buttons
Hide Buttons